A Phase I Study of Cetuximab in Combination With Gemcitabine and Radiation for Locally Advanced Pancreatic Cancer

BACKGROUND: Cetuximab is a monoclonal antibody against the epidermal growth factor receptor (EGFR). The primary goal of this phase I study was to determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of gemcitabine when combined with cetuximab plus radiation in patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chakravarthy, A. Bapsi, Tsai, Chiao Jillian, O'Brien, Nathan, Lockhart, A. Craig, Chan, Emily, Parikh, Alexander, Berlin, Jordan D., Merchant, Nipun
Formato: Artigo
Idioma:Inglês
Publicado em: International Society of Gastrointestinal Oncology 2012
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3433259/
https://ncbi.nlm.nih.gov/pubmed/23077684
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados